In this JCO Precision Oncology Article Insights episode, Miki Horiguchi summarizes two articles: “ Germline Susceptibility to Renal Cell Carcinoma and Implications for Genetic Screening, ” by Dr. Kate ...

Cases of the new COVID-19 variant NB.1.8.1, a descendent of the Omicron variant, are on the rise in some parts of the world, according to the World Health Organization (WHO). Currently, there are ...

A new COVID-19 variant that was unheard of just months ago is now projected to be the second-most common strain in the United States. Variant NB.1.8.1 was first detected in China in January but ...

COVID-19 cases rising in U.S. as new "variant of interest" emerges 05:08. The World Health Organization announced Tuesday it would step up its classification of the new COVID-19 variant JN.1 to a ...

Low-penetrant variants were identified in an additional 11 patients (1.8%). Eighty-nine percent of the moderate- to high-penetrant variants involved the major cancer susceptibility genes BRCA2, ATM, ...

As of mid-May, the variant had reached 10.7% of global reported COVID-19 cases, according to the World Health Organization (WHO). As of May 27, less than 20 cases of NB.1.8.1 had been reported in ...

The Centers for Disease Control and Prevention data shows that a new COVID variant, the KP.3 variant, is rising to dominance across the United States.. For the two-week period starting on May 26 ...

Research is under way to determine whether the mutation-laden lineage BA.2.86 has the potential for global spread — or whether it is nothing to worry about.

As of the week ending June 7, NB.1.8.1 is the second most dominant variant in the U.S., accounting for an estimated 37% of cases, according to the Centers for Disease Control and Prevention (CDC).